Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  HIV Infection

  Free Subscription


13.08.2018

10 AIDS
4 AIDS Res Hum Retroviruses
2 Antimicrob Agents Chemother
1 Antivir Ther
1 BMC Pediatr
1 Clin Infect Dis
2 HIV Med
1 Int J Dermatol
4 J Acquir Immune Defic Syndr
2 J Infect Dis
2 J Med Virol
8 J Virol
1 Nat Med
1 Nature
1 Pediatr Infect Dis J
1 PLoS Med
13 PLoS One
2 Vaccine
2 Virology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AIDS

  1. DELAUGERRE C, Rodriguez C, Capitant C, Nere ML, et al
    Drug resistance among patients who acquired HIV infection in a PrEP trial.
    AIDS. 2018 Aug 8. doi: 10.1097/QAD.0000000000001960.
    PubMed     Text format     Abstract available

  2. RHINES AS, Feldman MW, Bendavid E
    Modeling the implementation of population-level isoniazid preventive therapy for tuberculosis control in a high HIV-prevalence setting.
    AIDS. 2018 Aug 8. doi: 10.1097/QAD.0000000000001959.
    PubMed     Text format     Abstract available

  3. KROON E, Pham PT, Sirivichayakul S, Trichavaroj R, et al
    Transmission dynamics among participants initiating anti-retroviral therapy upon diagnosis of early acute HIV-1 infection in Thailand.
    AIDS. 2018 Aug 8. doi: 10.1097/QAD.0000000000001956.
    PubMed     Text format     Abstract available

  4. SHIBOSKI CH, Yao TJ, Russell JS, Ryder MI, et al
    The association between oral disease and type of antiretroviral therapy among perinatally HIV-Infected youth.
    AIDS. 2018 Aug 8. doi: 10.1097/QAD.0000000000001965.
    PubMed     Text format     Abstract available

  5. COLIN DE VERDIERE N, Durier C, Samri A, Meiffredy V, et al
    Immunogenicity and safety of yellow fever vaccine in HIV-1-infected patients: ANRS EP46 NOVAA.
    AIDS. 2018 Aug 8. doi: 10.1097/QAD.0000000000001963.
    PubMed     Text format     Abstract available

  6. PRICE JC, Seaberg EC, Stosor V, Witt MD, et al
    AST-to-platelet ratio index increases significantly 3 years prior to liver-related death in HIV-hepatitis-coinfected men.
    AIDS. 2018 Aug 8. doi: 10.1097/QAD.0000000000001977.
    PubMed     Text format     Abstract available

  7. KAMITANI E, Wichser ME, Adegbite AH, Mullins MM, et al
    Increasing prevalence of self-reported HIV pre-exposure prophylaxis (PrEP) use in published surveys - a systematic review and meta-analysis.
    AIDS. 2018 Aug 8. doi: 10.1097/QAD.0000000000001983.
    PubMed     Text format     Abstract available

  8. LLEDO GM, Carrasco I, Benitez-Gutierrez LM, Arias A, et al
    Regression of liver fibrosis after curing chronic hepatitis C with oral antivirals in patients with and without HIV coinfection.
    AIDS. 2018 Aug 8. doi: 10.1097/QAD.0000000000001966.
    PubMed     Text format     Abstract available

  9. NUNEZ O, Hernando V, Diaz A
    Estimating the number of people living with HIV and the undiagnosed fraction in Spain in 2013.
    AIDS. 2018 Aug 8. doi: 10.1097/QAD.0000000000001989.
    PubMed     Text format     Abstract available

  10. ZHANG X, Ding X, Zhu Y, Chong H, et al
    Structural and functional characterization of HIV-1 cell fusion inhibitor T20.
    AIDS. 2018 Aug 8. doi: 10.1097/QAD.0000000000001979.
    PubMed     Text format     Abstract available


    AIDS Res Hum Retroviruses

  11. LI K, Ou W, Feng Y, Sun J, et al
    Near Full-Length Genomic Characterization of a Novel HIV Type 1 Recombinant Form (CRF01_AE/B) Identified from Anhui, China.
    AIDS Res Hum Retroviruses. 2018 Aug 3. doi: 10.1089/AID.2018.0144.
    PubMed     Text format     Abstract available

  12. EZEONWUMELU I, Bartolo I, Martin F, Abecasis AB, et al
    Accidental father-to-son HIV-1 transmission during the seroconversion period.
    AIDS Res Hum Retroviruses. 2018 Aug 3. doi: 10.1089/AID.2018.0060.
    PubMed     Text format     Abstract available

  13. CYNAMON MH, Damianopoulos EN
    Modeling the HIV-1 Antiretroviral Therapeutic Drug Interaction.
    AIDS Res Hum Retroviruses. 2018 Aug 3. doi: 10.1089/AID.2018.0113.
    PubMed     Text format     Abstract available

  14. DHAMANAGE A, Thakar M, Paranjape RS
    HIV-1 mediated suppression of IFN-alpha production is associated with inhibition of IRF-7 translocation and PI3K/akt pathway in Plasmacytoid Dendritic cells.
    AIDS Res Hum Retroviruses. 2018 Aug 3. doi: 10.1089/AID.2018.0136.
    PubMed     Text format     Abstract available


    Antimicrob Agents Chemother

  15. ADEGBOLA A, Abutaima R, Olagunju A, Ijarotimi O, et al
    Effect of pregnancy on the pharmacokinetic interaction between efavirenz and lumefantrine in HIV-malaria co-infection.
    Antimicrob Agents Chemother. 2018 Aug 6. pii: AAC.01252.
    PubMed     Text format     Abstract available

  16. KANDLER JL, Mercante AD, Dalton TL, Ezewudo MN, et al
    Validation of novel Mycobacterium tuberculosis isoniazid resistance mutations not detectable by common molecular tests.
    Antimicrob Agents Chemother. 2018 Aug 6. pii: AAC.00974.
    PubMed     Text format     Abstract available


    Antivir Ther

  17. MEE TC, Aepfelbacher J, Krakora R, Chairez C, et al
    Carotid magnetic resonance imaging in persons living with HIV and 10-year atherosclerotic cardiovascular disease risk score.
    Antivir Ther. 2018 Aug 8. doi: 10.3851/IMP3258.
    PubMed     Text format     Abstract available


    BMC Pediatr

  18. PENDA CI, Moukoko CEE, Koum DK, Fokam J, et al
    Feasibility and utility of active case finding of HIV-infected children and adolescents by provider-initiated testing and counselling: evidence from the Laquintinie hospital in Douala, Cameroon.
    BMC Pediatr. 2018;18:259.
    PubMed     Text format     Abstract available


    Clin Infect Dis

  19. HADDOW LJ, Godi C, Sokolska M, Cardoso MJ, et al
    Brain perfusion, regional volumes and cognitive function in HIV positive patients treated with protease inhibitor monotherapy.
    Clin Infect Dis. 2018 Jul 31. pii: 5062987. doi: 10.1093.
    PubMed     Text format     Abstract available


    HIV Med

  20. LAM JO, Barnell GM, Merchant M, Ellis CG, et al
    Acceptability of high-resolution anoscopy for anal cancer screening in HIV-infected patients.
    HIV Med. 2018 Aug 6. doi: 10.1111/hiv.12663.
    PubMed     Text format     Abstract available

  21. SEERS T, Vassallo P, Pollock K, Thornhill JP, et al
    CD4:CD8 ratio in children with perinatally acquired HIV-1 infection.
    HIV Med. 2018 Aug 6. doi: 10.1111/hiv.12642.
    PubMed     Text format     Abstract available


    Int J Dermatol

  22. DOKTOR V, Hadi A, Hadi A, Phelps R, et al
    Erythema elevatum diutinum: a case report and review of literature.
    Int J Dermatol. 2018 Aug 3. doi: 10.1111/ijd.14169.
    PubMed     Text format     Abstract available


    J Acquir Immune Defic Syndr

  23. CHRISTENSEN-QUICK A, Chaillon A, Yek C, Zanini F, et al
    Influenza Vaccination Can Broadly Activate the HIV Reservoir During Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2018 Aug 1. doi: 10.1097/QAI.0000000000001829.
    PubMed     Text format    

  24. BUKOWSKI LA, Chandler CJ, Creasy SL, Matthews DD, et al
    Characterizing the HIV Care Continuum and Identifying Barriers and Facilitators to HIV Diagnosis and Viral Suppression among Black Transgender Women in the United States.
    J Acquir Immune Defic Syndr. 2018 Aug 2. doi: 10.1097/QAI.0000000000001831.
    PubMed     Text format     Abstract available

  25. SPINELLI MA, Scott HM, Vittinghoff E, Liu AY, et al
    A Panel Management and Patient Navigation Intervention is Associated with Earlier PrEP Initiation in A Safety-Net Primary Care Health System.
    J Acquir Immune Defic Syndr. 2018 Aug 1. doi: 10.1097/QAI.0000000000001828.
    PubMed     Text format     Abstract available

  26. ROSENBERG NE, Bhushan NL, Vansia D, Phanga T, et al
    Comparing Youth Friendly Health Services to the Standard of Care through "Girl Power-Malawi": A Quasi-Experimental Cohort Study.
    J Acquir Immune Defic Syndr. 2018 Aug 1. doi: 10.1097/QAI.0000000000001830.
    PubMed     Text format     Abstract available


    J Infect Dis

  27. DARCIS G, Berkhout B
    HIV resistance to dolutegravir: are we looking at the wrong place?
    J Infect Dis. 2018 Aug 2. pii: 5063806. doi: 10.1093.
    PubMed     Text format    

  28. NAMAZI G, Fajnzylber JM, Aga E, Bosch R, et al
    The Control of HIV after Antiretroviral Medication Pause (CHAMP) study: post-treatment controllers identified from 14 clinical studies.
    J Infect Dis. 2018 Aug 6. pii: 5067282. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Med Virol

  29. FLORES GL, Cruz HM, Miguel JC, Potsch DV, et al
    Assessing Hepatitis B immunity using dried blood spot samples from HIV(+) individuals.
    J Med Virol. 2018 Aug 7. doi: 10.1002/jmv.25275.
    PubMed     Text format     Abstract available

  30. KAHYESH-ESFANDIARY R, Sadigh ZA, Esghaei M, Bastani MN, et al
    Detection of HCV Genome in Peripheral Blood Mononuclear Cells of Iranian Seropositive and HCV RNA negative in Plasma of Patients with Beta-thalassemia Major: Occult HCV Infection.
    J Med Virol. 2018 Aug 9. doi: 10.1002/jmv.25279.
    PubMed     Text format     Abstract available


    J Virol

  31. PAN T, Peng Z, Tan L, Zou F, et al
    Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Potently Inhibit the Replication of Zika Viruses by Inducing the Degradation of AXL.
    J Virol. 2018 Aug 1. pii: JVI.01018-18. doi: 10.1128/JVI.01018.
    PubMed     Text format     Abstract available

  32. ANANG S, Kaushik N, Hingane S, Kumari A, et al
    Potent inhibition of hepatitis E virus release by a cyclic peptide inhibitor of the interaction between viral open reading frame 3 protein and host tumor susceptibility gene 101.
    J Virol. 2018 Aug 1. pii: JVI.00684-18. doi: 10.1128/JVI.00684.
    PubMed     Text format     Abstract available

  33. WANG Z, Wang W, Cui YC, Pan Q, et al
    HIV-1 employs multiple mechanisms to resist Cas9/sgRNA targeting the viral primer binding site.
    J Virol. 2018 Aug 1. pii: JVI.01135-18. doi: 10.1128/JVI.01135.
    PubMed     Text format     Abstract available

  34. OSEI KUFFOUR E, Schott K, Jaguva Vasudevan AA, Holler J, et al
    USP18 (UBP43) Abrogates p21-Mediated Inhibition of HIV-1.
    J Virol. 2018 Aug 1. pii: JVI.00592-18. doi: 10.1128/JVI.00592.
    PubMed     Text format     Abstract available

  35. CHONG H, Zhu Y, Yu D, He Y, et al
    Structural and Functional Characterization of Membrane Fusion Inhibitors with Extremely Potent Activity against HIV-1, HIV-2, and Simian Immunodeficiency Virus.
    J Virol. 2018 Aug 8. pii: JVI.01088-18. doi: 10.1128/JVI.01088.
    PubMed     Text format     Abstract available

  36. PHILLIPS B, Van Rompay KKA, Rodriguez-Nieves J, Lorin C, et al
    Adjuvant-dependent enhancement of HIV Env-specific antibody responses in infant rhesus macaques.
    J Virol. 2018 Aug 8. pii: JVI.01051-18. doi: 10.1128/JVI.01051.
    PubMed     Text format     Abstract available

  37. RANKOVIC S, Ramalho R, Aiken C, Rousso I, et al
    PF74 reinforces the HIV-1 capsid to impair reverse transcription-induced uncoating.
    J Virol. 2018 Aug 8. pii: JVI.00845-18. doi: 10.1128/JVI.00845.
    PubMed     Text format     Abstract available

  38. CARNES SK, Zhou J, Aiken C
    HIV-1 Engages a Dynein-Dynactin-BICD2 Complex for Infection and Transport to the Nucleus.
    J Virol. 2018 Aug 1. pii: JVI.00358-18. doi: 10.1128/JVI.00358.
    PubMed     Text format     Abstract available


    Nat Med

  39. OKOYE AA, Hansen SG, Vaidya M, Fukazawa Y, et al
    Early antiretroviral therapy limits SIV reservoir establishment to delay or prevent post-treatment viral rebound.
    Nat Med. 2018 Aug 6. pii: 10.1038/s41591-018-0130.
    PubMed     Text format     Abstract available


    Nature

  40. DICK RA, Zadrozny KK, Xu C, Schur FKM, et al
    Inositol phosphates are assembly co-factors for HIV-1.
    Nature. 2018 Aug 1. pii: 10.1038/s41586-018-0396.
    PubMed     Text format     Abstract available


    Pediatr Infect Dis J

  41. BLIGNAUT E, Rossouw TM, Becker PJ, Mavuso DS, et al
    Gingival Recession and Localized Aggressive Periodontitis Among HIV-Infected Children and Adolescents Receiving Antiretroviral Therapy.
    Pediatr Infect Dis J. 2018 Aug 9. doi: 10.1097/INF.0000000000002166.
    PubMed     Text format     Abstract available


    PLoS Med

  42. FOX MP, Bor J, Brennan AT, MacLeod WB, et al
    Correction: Estimating retention in HIV care accounting for patient transfers: A national laboratory cohort study in South Africa.
    PLoS Med. 2018;15:e1002643.
    PubMed     Text format     Abstract available


    PLoS One

  43. EJIGU Y, Tadesse B
    HIV testing during pregnancy for prevention of mother-to-child transmission of HIV in Ethiopia.
    PLoS One. 2018;13:e0201886.
    PubMed     Text format     Abstract available

  44. NOGUEIRA BMF, Rolla VC, Akrami KM, Kiene SM, et al
    Correction: Factors associated with tuberculosis treatment delay in patients co-infected with HIV in a high prevalence area in Brazil.
    PLoS One. 2018;13:e0202292.
    PubMed     Text format     Abstract available

  45. CHEN Q, Sun Y, Sun W, Hao M, et al
    Trends of HIV incidence and prevalence among men who have sex with men in Beijing, China: Nine consecutive cross-sectional surveys, 2008-2016.
    PLoS One. 2018;13:e0201953.
    PubMed     Text format     Abstract available

  46. GEBREMEDHIN S
    Development of a new model for estimating maternal mortality ratio at national and sub-national levels and its application for describing sub-national variations of maternal death in Ethiopia.
    PLoS One. 2018;13:e0201990.
    PubMed     Text format     Abstract available


  47. Correction: Clinic-based evaluation study of the diagnostic accuracy of a dual rapid test for the screening of HIV and syphilis in pregnant women in Nigeria.
    PLoS One. 2018;13:e0202122.
    PubMed     Text format     Abstract available

  48. RZESZUTEK M
    A longitudinal analysis of posttraumatic growth and affective well-being among people living with HIV: The moderating role of received and provided social support.
    PLoS One. 2018;13:e0201641.
    PubMed     Text format     Abstract available

  49. CHILIZA N, Du Toit M, Wasserman S
    Outcomes of HIV-associated pneumocystis pneumonia at a South African referral hospital.
    PLoS One. 2018;13:e0201733.
    PubMed     Text format     Abstract available

  50. FLOYD S, Ayles H, Schaap A, Shanaube K, et al
    Towards 90-90: Findings after two years of the HPTN 071 (PopART) cluster-randomized trial of a universal testing-and-treatment intervention in Zambia.
    PLoS One. 2018;13:e0197904.
    PubMed     Text format     Abstract available

  51. GOTTERT A, Pulerwitz J, Siu G, Katahoire A, et al
    Male partners of young women in Uganda: Understanding their relationships and use of HIV testing.
    PLoS One. 2018;13:e0200920.
    PubMed     Text format     Abstract available

  52. LARSON BA, Bii M, Halim N, Rohr JK, et al
    Incremental treatment costs for HIV-infected women initiating antiretroviral therapy during pregnancy: A 24-month micro-costing cohort study for a maternal and child health clinic in Kenya.
    PLoS One. 2018;13:e0200199.
    PubMed     Text format     Abstract available

  53. MOYO S, Young PW, Gouws E, Naidoo I, et al
    Equity of antiretroviral treatment use in high HIV burden countries: Analyses of data from nationally-representative surveys in Kenya and South Africa.
    PLoS One. 2018;13:e0201899.
    PubMed     Text format     Abstract available

  54. QIAO S, Li X, Zhou Y, Shen Z, et al
    Attitudes toward evidence-based practices, occupational stress and work-related social support among health care providers in China: A SEM analysis.
    PLoS One. 2018;13:e0202166.
    PubMed     Text format     Abstract available

  55. O'ROURKE SM, Byrne G, Tatsuno G, Wright M, et al
    Robotic selection for the rapid development of stable CHO cell lines for HIV vaccine production.
    PLoS One. 2018;13:e0197656.
    PubMed     Text format     Abstract available


    Vaccine

  56. ITELL HL, McGuire EP, Muresan P, Cunningham CK, et al
    Development and application of a multiplex assay for the simultaneous measurement of antibody responses elicited by common childhood vaccines.
    Vaccine. 2018 Aug 4. pii: S0264-410X(18)31017.
    PubMed     Text format     Abstract available

  57. SPINA FG, Gouvea A, Succi RCM, Calanca F, et al
    Immune response to a Tdap booster in vertically HIV-infected adolescents.
    Vaccine. 2018 Aug 4. pii: S0264-410X(18)31012.
    PubMed     Text format     Abstract available


    Virology

  58. NUNES JM, Furtado MN, de Morais Nunes ER, Sucupira MCA, et al
    Modulation of epigenetic factors during the early stages of HIV-1 infection in CD4(+) T cells in vitro.
    Virology. 2018;523:41-51.
    PubMed     Text format     Abstract available

  59. MEIER K, Jaguva Vasudevan AA, Zhang Z, Bahr A, et al
    Equine MX2 is a restriction factor of equine infectious anemia virus (EIAV).
    Virology. 2018;523:52-63.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: